Related references
Note: Only part of the references are listed.Variants within the nitric oxide synthase 1 gene are associated with stroke susceptibility
Helena Manso et al.
ATHEROSCLEROSIS (2012)
Alcohol Consumption, Genetic Variants in Alcohol Deydrogenases, and Risk of Cardiovascular Diseases: A Prospective Study and Meta-Analysis
Dagmar Drogan et al.
PLOS ONE (2012)
Rare Variants in APP, PSEN1 and PSEN2 Increase Risk for AD in Late-Onset Alzheimer's Disease Families
Carlos Cruchaga et al.
PLOS ONE (2012)
Association of TMEM106B Gene Polymorphism With Age at Onset in Granulin Mutation Carriers and Plasma Granulin Protein Levels
Carlos Cruchaga et al.
ARCHIVES OF NEUROLOGY (2011)
ssociation and Expression Analyses With Single-Nucleotide Polymorphisms in TOMM40 in Alzheimer Disease
Carlos Cruchaga et al.
ARCHIVES OF NEUROLOGY (2011)
Genome partitioning of genetic variation for complex traits using common SNPs
Jian Yang et al.
NATURE GENETICS (2011)
Common variants at MS4A4/MS4A6E, CD2AP, CD33 and EPHA1 are associated with late-onset Alzheimer's disease
Adam C. Naj et al.
NATURE GENETICS (2011)
Common variants at ABCA7, MS4A6A/MS4A4E, EPHA1, CD33 and CD2AP are associated with Alzheimer's disease
Paul Hollingworth et al.
NATURE GENETICS (2011)
Plasma apolipoprotein E and Alzheimer disease risk The AIBL study of aging
V. B. Gupta et al.
NEUROLOGY (2011)
Fine Mapping of Genetic Variants in BIN1, CLU, CR1 and PICALM for Association with Cerebrospinal Fluid Biomarkers for Alzheimer's Disease
John S. K. Kauwe et al.
PLOS ONE (2011)
Human apoE Isoforms Differentially Regulate Brain Amyloid-β Peptide Clearance
Joseph M. Castellano et al.
SCIENCE TRANSLATIONAL MEDICINE (2011)
APOE Predicts Amyloid-Beta but Not Tau Alzheimer Pathology in Cognitively Normal Aging
John C. Morris et al.
ANNALS OF NEUROLOGY (2010)
A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer's disease
A. D. Roses et al.
PHARMACOGENOMICS JOURNAL (2010)
SNPs Associated with Cerebrospinal Fluid Phospho-Tau Levels Influence Rate of Decline in Alzheimer's Disease
Carlos Cruchaga et al.
PLOS GENETICS (2010)
Decreased Cerebrospinal Fluid Aβ42 Correlates with Brain Atrophy in Cognitively Normal Elderly
Anne M. Fagan et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarker Signature in Alzheimer's Disease Neuroimaging Initiative Subjects
Leslie M. Shaw et al.
ANNALS OF NEUROLOGY (2009)
Cerebrospinal Fluid Biomarkers and Rate of Cognitive Decline in Very Mild Dementia of the Alzheimer Type
Barbara J. Snider et al.
ARCHIVES OF NEUROLOGY (2009)
Cerebrospinal Fluid β-Amyloid 42 and Tau Proteins as Biomarkers of Alzheimer-Type Pathologic Changes in the Brain
Tero Tapiola et al.
ARCHIVES OF NEUROLOGY (2009)
Cortical Atrophy and Language Network Reorganization Associated with a Novel Progranulin Mutation
Carlos Cruchaga et al.
CEREBRAL CORTEX (2009)
Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease
Denise Harold et al.
NATURE GENETICS (2009)
Alzheimer's disease risk variants show association with cerebrospinal fluid amyloid beta
John S. K. Kauwe et al.
NEUROGENETICS (2009)
Relationships between biomarkers in aging and dementia
W. J. Jagust et al.
NEUROLOGY (2009)
Human LDL receptor enhances sequestration of ApoE4 and VLDL remnants on the surface of hepatocytes but not their internalization in mice
Michael Altenburg et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2008)
Impact of Apolipoprotein E (ApoE) Polymorphism on Brain ApoE Levels
David R. Riddell et al.
JOURNAL OF NEUROSCIENCE (2008)
Variation in MAPT is associated with cerebrospinal fluid tau levels in the presence of amyloid-beta deposition
John S. K. Kauwe et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Mendelian randomization: Using genes as instruments for making causal inferences in epidemiology
Debbie A. Lawlor et al.
STATISTICS IN MEDICINE (2008)
Extreme cerebrospinal fluid amyloid β levels identify family with late-onset Alzheimer's disease presenilin 1 mutation
John S. K. Kauwe et al.
ANNALS OF NEUROLOGY (2007)
Cerebrospinal fluid tau/β-amyloid42 ratio as a prediction of cognitive decline in nondemented older adults
Anne M. Fagan et al.
ARCHIVES OF NEUROLOGY (2007)
Mendelian randomization as an instrumental variable approach to causal inference
Vanessa Didelez et al.
STATISTICAL METHODS IN MEDICAL RESEARCH (2007)
Principal components analysis corrects for stratification in genome-wide association studies
Alkes L. Price et al.
NATURE GENETICS (2006)
PupaSuite: finding functional single nucleotide polymorphisms for large-scale genotyping purposes
Lucia Conde et al.
NUCLEIC ACIDS RESEARCH (2006)
Limits to causal inference based on mendelian randomization: A comparison with randomized controlled trials
D Nitsch et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2006)
Inverse relation between in vivo amyloid imaging load and cerebrospinal fluid Aβ42 in humans
AM Fagan et al.
ANNALS OF NEUROLOGY (2006)
C-reactive protein and its role in metabolic syndrome: mendelian randomisation study
NJ Timpson et al.
LANCET (2005)
The low density lipoprotein receptor regulates the level of central nervous system human and murine apolipoprotein E but does not modify amyloid plaque pathology in PDAPP mice
JD Fryer et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
APOE ε3/ε4 heterozygotes have an elevated proportion of apolipoprotein E4 in cerebrospinal fluid relative to plasma, independent of Alzheimer's disease diagnosis
H Fukumoto et al.
EXPERIMENTAL NEUROLOGY (2003)
TaqMan Systems for Genotyping of Disease-Related Polymorphisms Present in the Gene Encoding Apolipoprotein E
Werner Koch et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2002)
Share Paper
